Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer’s Disease but Not in Parkinson’s Disease or Frontotemporal Dementia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer’s Disease but Not in Parkinson’s Disease or Frontotemporal Dementia
Authors
Keywords
-
Journal
ACS Chemical Neuroscience
Volume 12, Issue 8, Pages 1376-1383
Publisher
American Chemical Society (ACS)
Online
2021-04-14
DOI
10.1021/acschemneuro.1c00010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Longitudinal Amyloid-β PET in Atypical Alzheimer’s Disease and Frontotemporal Lobar Degeneration
- (2020) Jennifer L. Whitwell et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
- (2020) Nicolas R. Barthélemy et al. Alzheimers Research & Therapy
- Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration
- (2020) Alberto Benussi et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease
- (2020) Amy F. T. Arnsten et al. Alzheimers & Dementia
- Classifications of Neurodegenerative Disorders Using a Multiplex Blood Biomarkers-Based Machine Learning Model
- (2020) Chin-Hsien Lin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal Subjects
- (2019) Lih-Fen Lue et al. Frontiers in Aging Neuroscience
- Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
- (2018) Michelle M. Mielke et al. Alzheimers & Dementia
- The aged rhesus macaque manifests Braak stage III/IV Alzheimer's-like pathology
- (2018) Constantinos D. Paspalas et al. Alzheimers & Dementia
- Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer’s Disease
- (2018) Charlotte E. Teunissen et al. JOURNAL OF ALZHEIMERS DISEASE
- The Relation Between Brain Amyloid Deposition, Cortical Atrophy, and Plasma Biomarkers in Amnesic Mild Cognitive Impairment and Alzheimer’s Disease
- (2018) Ling-Yun Fan et al. Frontiers in Aging Neuroscience
- Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia
- (2018) Miguel A. Santos-Santos et al. JAMA Neurology
- A clinicopathological approach to the diagnosis of dementia
- (2017) Fanny M. Elahi et al. Nature Reviews Neurology
- Clinical marker for Alzheimer disease pathology in logopenic primary progressive aphasia
- (2017) Lucia A.A. Giannini et al. NEUROLOGY
- Plasma Tau Levels in Cognitively Normal Middle-Aged and Older Adults
- (2017) Ming-Jang Chiu et al. Frontiers in Aging Neuroscience
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles
- (2016) Shieh-Yueh Yang et al. JOURNAL OF NANOBIOTECHNOLOGY
- The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer’s disease
- (2015) Kiwamu Watanabe et al. Molecular Brain
- Plasma Aβ but Not Tau is Related to Brain PiB Retention in Early Alzheimer’s Disease
- (2014) Kai-Yuan Tzen et al. ACS Chemical Neuroscience
- Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine
- (2014) David J. Irwin et al. ACTA NEUROPATHOLOGICA
- Instrumental activities of daily living are impaired in Parkinson’s disease patients with mild cognitive impairment.
- (2014) Eva Pirogovsky et al. NEUROPSYCHOLOGY
- Combined Plasma Biomarkers for Diagnosing Mild Cognition Impairment and Alzheimer’s Disease
- (2013) Ming-Jang Chiu et al. ACS Chemical Neuroscience
- Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early alzheimer's disease
- (2013) Ming-Jang Chiu et al. HUMAN BRAIN MAPPING
- New Assay for Old Markers-Plasma Beta Amyloid of Mild Cognitive Impairment and Alzheimer's Disease
- (2012) M.J. Chiu et al. Current Alzheimer Research
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
- (2012) Irene Litvan et al. MOVEMENT DISORDERS
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
- (2011) Katya Rascovsky et al. BRAIN
- Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
- (2011) Heiko Braak et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Classification of primary progressive aphasia and its variants
- (2011) M. L. Gorno-Tempini et al. NEUROLOGY
- Pathological correlates of frontotemporal lobar degeneration in the elderly
- (2010) Atik Baborie et al. ACTA NEUROPATHOLOGICA
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
- (2010) Christopher C. Rowe et al. NEUROBIOLOGY OF AGING
- Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update
- (2009) Ian R. A. Mackenzie et al. ACTA NEUROPATHOLOGICA
- The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease
- (2007) Lidia Glodzik-Sobanska et al. NEUROBIOLOGY OF AGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now